(PharmaNewsWire.Com, June 17, 2019 ) The global brain monitoring market is expected to reach USD 12.22 Billion by 2021 from USD 8.80 Billion in 2016, growing at a CAGR of 6.8% from 2016 to 2021.
On the basis of product, the brain monitoring market is segmented into devices and accessories. The devices segment is estimated to command the largest share in 2016. The large share of this segment can be attributed to factors like increasing incidence of neurological, neurodegenerative, psychotic, and sleep disorders; the need for early diagnosis; availability of innovative portable and wearable home-based monitoring devices; and increasing patient awareness. On the basis of end user, the brain monitoring market is segmented into hospitals, neurology centers, clinics and ambulatory surgical centers (ASCs), diagnostic centers, ambulances and centers, and other end users.
Based on type, the brain monitoring devices market is segmented into MRI scanners, CT scanners, PET scanners, electroencephalography devices, cerebral oximeters, intracranial pressure monitors, sleep monitoring devices, electromyography devices, TCD devices, and magnetoencephalography devices. The MRI scanners segment is estimated to account for the largest share in 2016.
This is due to its advantages over other imaging techniques, such as superior image quality; technological advancements in MRI scanners; and growing application of MRI in the diagnosis and staging of neurological disorders. The large share of this segment can be attributed to the fact that MRI is an important, superior, and sensitive imaging technique for brain imaging in routine clinical practice.
Based on disease type, the brain monitoring market is segmented into epilepsy, dementia, Parkinson’s disease, Huntington’s disease, headache disorders, strokes, traumatic brain injuries, sleep disorders, and other diseases. In 2016, the market is estimated to be dominated by traumatic brain injuries. The large share of this segment can be attributed to the growing incidence of TBIs globally owing to various factors like, increasing occurrence of falls, blunt trauma, and motor vehicle crashes among other causes of traumatic brain injuries and along with the increasing aging population.
Based on region, the global brain monitoring market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market by the end of 2016. This large share can be attributed to the increase in the geriatric population, growing incidence of various neurodegenerative and sleep disorders, availability of insurance coverage for brain monitoring techniques, government initiatives to support technological advancement in the field of neurosciences, and increasing awareness about the benefits of early diagnosis of diseases.
Prominent players in the brain monitoring market include Natus Medical Inc. (U.S.), Nihon Kohden Corporation (Japan), Philips Healthcare (Netherlands), GE Healthcare (U.K.) Siemens Healthineers (Germany), Compumedics Ltd. (Australia), Electrical Geodesics Incorporated (U.S.), Medtronic plc (Ireland), CAS Medical Systems, Inc. (U.S.), and Advanced Brain Monitoring (U.S.).
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
